Table 3 Long-term outcome after TMA

In-hospital adverse event

 Death, n (%)

0 (0)

0 (0)

3 (14)

 < 0.05

 Major cardiovascular event, n (%)

0 (0)

0 (0)

3 (14)

 < 0.05

 Renal replacement therapy, n (%)

2 (8)

3 (10)

22 (100)

-

 Graft loss, n (%)

0 (0)

0 (0)

22 (100)

-

Clinical outcomes at last follow-up

 Time to last follow-up, months, median (IQR)

30 (14–46)

23 (16–48)

24 (3–58)

0.85

 Death, n (%)

1 (4)

4 (13)

1 (5)

0.49

 Serum creatinine levels, µmol/L, median (IQR)

145 (110–194)

193 (100–293)

-

0.26

 Graft loss, n (%)

0 (0)

6 (19)

-

0.03

 TCMR, n (%)

1 (4)

3 (10)

-

0.62

 ABMR, n (%)

2 (8)

4 (13)

-

0.68

 Recurrent TMA during follow-up, n (%)

2 (8)

5 (16)

6 (27)

0.23

 Retransplantation, n (%)

0 (0)

1 (3)

10 (45)

-